FDA enforcement comparison

Philips North America vs SCA Pharmaceuticals LLC: FDA Enforcement Comparison

Philips North America has been the subject of 23 FDA enforcement/approval records tracked by Argus HQ, compared to 3 for SCA Pharmaceuticals LLC.

Philips North America: 0 warning letters, 23 recalls, 0 approval records, 0 Form 483s.

SCA Pharmaceuticals LLC: 0 warning letters, 0 recalls, 0 approval records, 3 Form 483s.

Side by side

Philips North America — Warning letters0
SCA Pharmaceuticals LLC — Warning letters0
Philips North America — Recalls23
SCA Pharmaceuticals LLC — Recalls0
Philips North America — Approval records0
SCA Pharmaceuticals LLC — Approval records0
Philips North America — Form 483s0
SCA Pharmaceuticals LLC — Form 483s3

Timeline

Philips North America

Most recent FDA action: July 1, 2026

Full history →

SCA Pharmaceuticals LLC

Most recent FDA action: March 13, 2026

Full history →

Cite this comparison

Pre-formatted for a story, footnote, or reference list:

"Philips North America vs SCA Pharmaceuticals LLC: FDA Enforcement Comparison." Argus HQ, accessed July 15, 2026. https://argushq.ai/compare/philips-north-america-vs-sca-pharmaceuticals

Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗